Home › Actavis to spend $66 billion on Allerganvisit|article-5898166|mobile_home_category_body-6916|6
 

Keywords :   


Actavis to spend $66 billion on Allerganvisit|article-5898166|mobile_home_category_body-6916|6

2014-11-19 00:38:31| Biotech - Topix.net

Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products. CEO Brent Saunders said Monday that the combined company will have more than two dozen products in late-stage clinical testing, which is usually the last and most expensive development phase, and it will work to support research.

Tags: spend billion actavis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
03.07Hurricane Beryl Wind Speed Probabilities Number 18
03.07Hurricane Beryl Public Advisory Number 18
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 18
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
More »